This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Salesforce.com (CRM) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) closed the most recent trading day at $273.81, moving +1.27% from the previous trading session.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Is It Worth Investing in Salesforce.com (CRM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo
by Zacks Equity Research
Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo are included in this Analyst Blog.
Top Research Reports for Eli Lilly, Linde & Caterpillar
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT).
Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $278.29 in the latest trading session, marking a +1.98% move from the prior day.
Company News for Apr 16, 2024
by Zacks Equity Research
Companies in The News Are: TSLA, GS, SCHW, CRM, INFA
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Oracle's (ORCL) Exadata Platform to Enhance IHH's Operations
by Zacks Equity Research
Oracle (ORCL) announces that its Exadata platform has been selected by IHH Healthcare to enhance operational efficiency and patient outcomes.
Marks Cannot Sustain Rebound Amid High Bond Rates
by Mark Vickery
The 10-year bond yield was up on a specter of higher interest rates for longer.
Salesforce (CRM) in Takeover Talks With Informatica Per Reports
by Zacks Equity Research
If the acquisition of Informatica materializes, it will bolster Salesforce's (CRM) capabilities in data integration and management, a crucial aspect of its CRM platform.
Low Beta Tech Stocks to Consider for a Rebound Amid Heightened Market Volatility
by Shaun Pruitt
Several tech stocks on the Zacks Rank #1 (Strong Buy) list have beta ratios under 1.0, which suggests they should be less volatile than the broader market as they already appear to be in oversold territory.
The Zacks Analyst Blog Highlights AbbVie, Salesforce, General Electric, The TJX Companies and UBS Group
by Zacks Equity Research
AbbVie, Salesforce, General Electric, The TJX Companies and UBS Group are part of the Zacks top Analyst Blog.
Top Stock Reports for AbbVie, Salesforce & General Electric
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Salesforce, Inc. (CRM) and General Electric Company (GE).
Oracle's (ORCL) Cloud Service to Help Combat Money Laundering
by Zacks Equity Research
Oracle (ORCL) launches its Financial Services Compliance Agent, an AI-powered cloud service to help banks enhance their anti-money laundering and financial crime detection capabilities.
Salesforce.com (CRM) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $301.73, representing a -0.06% change from its previous close.
Is Trending Stock Salesforce Inc. (CRM) a Buy Now?
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Oracle (ORCL) Partners With Palantir to Offer AI Solutions
by Zacks Equity Research
Oracle (ORCL) collaborates with Palantir to deliver cloud and artificial intelligence solutions to businesses and governments around the world.
Microsoft (MSFT) Azure Likely to Face Scrutiny in South Africa
by Zacks Equity Research
Microsoft's (MSFT) Azure cloud business is likely to receive a formal complaint from South African competition watchdogs on concerns over abuse of power to squeeze out rivals.
Is Invesco Large Cap Growth ETF (PWB) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PWB
Varonis (VRNS) Unveils Security Solution for Microsoft Copilot
by Zacks Equity Research
Varonis (VRNS) unveils a cybersecurity solution for Microsoft's Copilot platform to support the latter's AI-driven tools before and after deployment.
Oracle's (ORCL) Solution Boosts North Greenbush's Efficiency
by Zacks Equity Research
Oracle's (ORCL) NetSuite for Government boosts efficiency in the operations of North Greenbush town to support the growing community.
Microsoft (MSFT) Splits Teams and Office to Counter EU Scrutiny
by Zacks Equity Research
Microsoft (MSFT) is set to sell Teams separately from its Office product globally. The decision comes after the company unbundled the two products in Europe to avert a possible EU antitrust fine.